MirSkin Aesthetics: Tabasum Mir MD

MirSkin Aesthetics operates under the medical direction of Dr. Tabasum Mir, a board-certified physician practicing in New York, NY, with a clinical focus on non-surgical aesthetic treatments and medically supervised weight management. The practice integrates injectable therapies, facial rejuvenation protocols, and body contouring services with peptide-based metabolic interventions designed for patients seeking alternatives to invasive procedures. Dr. Mir's approach combines dermatologic expertise with functional medicine principles to address both aesthetic concerns and underlying metabolic health factors that influence body composition and skin quality.

The clinic offers two GLP-1 receptor agonist peptides for weight management: semaglutide and tirzepatide. Semaglutide functions as a glucagon-like peptide-1 analog that regulates appetite and glucose metabolism, typically administered as a once-weekly subcutaneous injection with dosing protocols individualized based on patient response and tolerance. Tirzepatide represents a dual GIP/GLP-1 receptor agonist mechanism, targeting both glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 pathways for enhanced metabolic effects. These peptide therapies are prescribed as part of comprehensive weight management programs that include metabolic assessment, nutritional guidance, and ongoing monitoring of body composition changes. MirSkin Aesthetics also provides a full spectrum of injectable treatments including neuromodulators and dermal fillers, which are frequently combined with peptide protocols to address facial volume loss that may occur during weight reduction phases.

Dr. Tabasum Mir holds board certification and maintains memberships in multiple medical organizations relevant to aesthetic medicine and metabolic health. Her clinical methodology emphasizes evidence-based treatment selection, with protocols informed by current research in peptide pharmacology and aesthetic medicine outcomes. The practice utilizes before-and-after photographic documentation to track patient progress across both aesthetic and weight management interventions, allowing for objective assessment of treatment efficacy and protocol adjustments as needed. Dr. Mir conducts initial consultations to evaluate patient candidacy for peptide therapy, reviewing medical history, contraindications, and realistic outcome expectations before initiating treatment.

Patients at MirSkin Aesthetics in New York undergo in-person consultations where Dr. Mir performs clinical assessments and discusses treatment options specific to individual goals. The consultation process includes review of previous aesthetic treatments, current medications, and metabolic health markers relevant to peptide therapy eligibility. For patients initiating semaglutide or tirzepatide, the practice provides injection training, supplies administration materials, and schedules follow-up appointments to monitor weight loss progression, manage potential side effects, and adjust dosing protocols. Injectable aesthetic treatments such as neuromodulators and fillers are often coordinated with peptide therapy timelines to optimize facial contouring results as body composition changes occur.

MirSkin Aesthetics requires in-person visits for all consultations and treatment administration, serving patients throughout the New York metropolitan area who prefer direct physician oversight for peptide therapy and aesthetic procedures. The practice maintains active communication channels for patient questions regarding medication protocols, side effect management, and treatment scheduling. Dr. Mir's integration of metabolic peptides with traditional aesthetic services provides a comprehensive approach for patients addressing both weight management and age-related facial changes within a single medical practice, eliminating the need to coordinate care across multiple providers for related treatment goals.